Patients in the survival group had significantly higher levels of lymphocyte count, serum albumin, hemoglobin, prognostic nutritional index (PNI), lymphocyte-to-monocyte ratio (LMR), hemoglobin-to-red cell distribution width ratio (HRR), hemoglobin-albumin-lymphocyte-platelet (HALP) score, albumin-to-globulin ratio (ALB/GLB), as well as a greater proportion of stage I cases and patients with high-to-moderate tumor differentiation. Here, ALB is linked to neoplasm.